Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Zero-based budgeting for family vacations allocates funds to travel, lodging, and activities, keeping your trip affordable without surprises.
17,096 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
When MoonLake Immunotherapeutics announced a larger-than-expected secondary offering, the stock wilted. This guide br...
Unlock the signals behind American Water Works earnings calls. Learn how to read the transcript, spot growth drivers,...
This year’s Federal Reserve stress tests delivered a standout message: America’s banks are sturdier than ever. All ma...
A big fund trimmed its ACMR stake, yet the stock jumped 170% in a short window. This article breaks down what happene...
The GRID fund has surged about 23% in 2026, outpacing the traditional utilities ETF XLU as AI-enabled grid modernizat...
A New York-based issuer sells rated notes backed by a pool of bitcoin-backed consumer loans, signaling a milestone fo...
In seven days, five senior Google AI researchers resigned, fueling concerns that Alphabet is losing its AI edge. The ...
Investors are rethinking AI bets as Bank of America flags doubts around revolution emerging. The new caution hints at...
Dreaming of owning a sports team? This guide explains how everyday investors can participate in the sports ecosystem,...
President Donald Trump announces a sweeping 10% global tariff on imports, seeking to salvage a faltering trade agenda...
Intuitive Machines faced a notable stock slide this week as broader space-sector volatility and milestone timing conc...